Transcranial direct current stimulation is a noninvasive brain stimulation technique that has been studied for the treatment of neuropsychiatric disorders in adults, with minimal side effects. The objective of this study is to report the feasibility, tolerability, and the short-term adverse effects of transcranial direct current stimulation in children from 5 to 12 years of age. It is a naturalistic study of 14 children who underwent 10 sessions of transcranial direct current stimulation as an alternative, off-label, and open-label treatment for various languages disorders. Frequency, intensity, adverse effects, and perception of improvement reported by parents were collected. The main side effects detected were tingling (28.6%) and itching (28.6%), acute mood changes (42.9%), and irritability (35.7%). Transcranial direct current stimulation is a feasible and tolerable technique in children, although studies regarding plastic and cognitive changes in children are needed to confirm its safety. In conclusion, this is a naturalistic report in which we considered transcranial direct current stimulation as feasible in children.
SchulzRGerloffCHummelFC. Non-invasive brain stimulation in neurological diseases. Neuropharmacology. 2013;64:579–587.
2.
BerlimMTVan den EyndeFDaskalakisZJ. Clinical utility of transcranial direct current stimulation (tDCS) for treating major depression: a systematic review and meta-analysis of randomized, double-blind and sham-controlled trials. J Psychiatr Res. 2013;47:1–7.
3.
JacobsonLKoslowskyM, Lavidor M. tDCS polarity effects in motor and cognitive domains: a meta-analytical review. Exp Brain Res. 2012;216:1–10.
4.
O'ConnellNEWandBMMarstonL. Non-invasive brain stimulation techniques for chronic pain. A report of a Cochrane systematic review and meta-analysis. Eur J Phys Rehabil Med. 2011;47:309–326.
5.
BenningerDHLomarevMLopezG. Transcranial direct current stimulation for the treatment of Parkinson's disease. J Neurol Neurosurg Psychiatry. 2010;81:1105–1111.
6.
BrunoniARAmaderaJBerbelB. A systematic review on reporting and assessment of adverse effects associated with transcranial direct current stimulation. Int J Neuropsychopharmacol. 2011;14:1133–1145.
7.
BrunoniARNitscheMABologniniN. Clinical research with transcranial direct current stimulation (tDCS): challenges and future directions. Brain Stimul. 2012;5:175–195.
8.
KolbBTeskeyGC. Age, experience, injury, and the changing brain. Dev Psychobiol. Nov 242010.
9.
StortelderFPloegmakers-BurgM. Adolescence and the reorganization of infant development: a neuro-psychoanalytic model. J Am Acad Psychanal Dyn Psychiatry. 2010;38:503–531.
10.
KolbBTeskeyGC. Age, experience, injury, and the changing brain. Dev Psychobiol. 2012;54:311–325.
11.
MattaiAMillerRWeisingerB. Tolerability of transcranial direct current stimulation in childhood-onset schizophrenia. Brain Stimul. 2011;4:275–280.
12.
FryeRERotenbergAOusleyMPascual-LeoneA. Transcranial magnetic stimulation in child neurology: current and future directions. J Child Neurol. 2008;23:79–96.
13.
WalterGTormosJMIsraelJAPascual-LeoneA. Transcranial magnetic stimulation in young persons: a review of known cases. J Child Adolesc Psychopharmacol. 2001;11:69–75.
14.
Research Units on Pediatric Psychopharmacology (RUPP) Autism Network. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity. Arch Gen Psychiatry. 2005;62:1266–1274.
15.
BiksonMRahmanADattaA. High-resolution modeling assisted design of customized and individualized transcranial direct current stimulation protocols. Neuromodulation. 2012;15:306–315.
16.
United States Government Accountability Office PDR. Pediatric Drug Research: Studies Conducted Under Best Pharmaceuticals for Children Act. Washington, DC: United States Government Accountability Office, 2007; GAO-07-557.2007.
17.
ShahSSHallMGoodmanDM. Off-label drug use in hospitalized children. Arch Pediatr Adolesc Med. 2007;161:282–290.
18.
ShamliyanTKaneRL. Clinical research involving children: registration, completeness, and publication. Pediatrics. 2012;129:1291–1300.
19.
Cohen KadoshRLevyNO'SheaJ. The neuroethics of non-invasive brain stimulation. Curr Biol. 2012;22:108–111.
20.
BleicherEW. Encouraging research and development of pediatric medical devices through legislative and regulatory action: the Pediatric Medical Device Safety and Improvement Act of 2007 in context. Food Drug Law J. 2009;64:531–564.
21.
BrunoniARPinheiroFSBoggioPS. Estimulação Transcraniana por Corrente Contínua. Neuromodulação Terapêutica Princípios e Avanços da Estimulação Cerebral não invasiva em Neurologia, Reabilitação, Psiquiatria e Neuropsicologia. 1st ed. São Paulo, Brazil: Savier Editora de Livros Médicos Ltda.; 2012:65–75.
22.
VargaETTerneyDAtkinsMD. Transcranial direct current stimulation in refractory continuous spikes and waves during slow sleep: a controlled study. Epilepsy Res. 2011;97:142–145.
23.
KwonHJLimWSLimMH. 1-Hz low frequency repetitive transcranial magnetic stimulation in children with Tourette's syndrome. Neurosci Lett. 2011;492:1–4.
24.
KirtonAChenRFriefeldS. Contralesional repetitive transcranial magnetic stimulation for chronic hemiparesis in subcortical paediatric stroke: a randomised trial. Lancet Neurol. 2008;7:507–513.
25.
SokhadzeEBaruthJTasmanA. Low-frequency repetitive transcranial magnetic stimulation (rTMS) affects event-related potential measures of novelty processing in autism. App Psychophysiol Biofeedback. 2010;35:147–161.
26.
EnticottPGRinehartNJTongeBJ. Repetitive transcranial magnetic stimulation (rTMS) improves movement-related cortical potentials in autism spectrum disorders. Brain Stimul. 2012;5:30–37.
27.
RotenbergABaeEHTakeokaM. Repetitive transcranial magnetic stimulation in the treatment of epilepsia partialis continua. Epilepsy Behav. 2009;14:253–257.
28.
GilbertDLGarveyMABansalAS. Should transcranial magnetic stimulation research in children be considered minimal risk?Clin Neurophysiol. 2004;115:1730–1739.
29.
D'AgatiDBlochYLevkovitzY. rTMS for adolescents: safety and efficacy considerations. Psychiatry Res. 2010;177:280–285.
